Table 2 Frequency distribution of used drugs among two groups with and without HD
Drug categories | Without IHD (N = 1218) | With IHD (N = 300) | P value |
|---|---|---|---|
H2 blocker | 784 (64.4%) | 221 (73.7%) | 0.187 |
ACE inhibitor | 21 (1.7%) | 11 (3.7%) | 0.036 |
Beta blocker | 118 (9.7%) | 103 (34.3%) | < 0.001 |
calcium blocker | 74 (6.1%) | 36 (12%) | < 0.001 |
Diuretic | 39 (3.2%) | 47 (15.7%) | < 0.001 |
Anti-hyperglycemic | 64 (5.3%) | 42 (14%) | < 0.001 |
LABA | 15 (1.2%) | 7 (2.3%) | 0.274 |
ICS | 15 (1.2%) | 5 (1.7%) | 0.766 |
LABA and ICS | 22 (1.8%) | 7 (2.3%) | 0.841 |
ARB | 203 (16.7%) | 109 (36.3%) | < 0.001 |
Immunosuppressive | 9 (0.7%) | 3 (1%) | 0.647 |
Levothyroxine | 77 (6.3%) | 21 (7%) | 0.845 |
Anti-hyperlipidemic | 155 (12.7%) | 126 (42%) | < 0.001 |
Anticoagulant | 19 (1.6%) | 18 (6%) | 0.001 |
ARB and diuretic | 2 (0.2%) | 3 (1%) | 0.042 |
SSRI | 41 (3.4%) | 8 (2.7%) | 0.310 |
Anticonvulsant | 49 (4%) | 26 (8.7%) | 0.017 |
Antipsychotic | 29 (2.4%) | 4 (1.3%) | 0.272 |
Methylprednisolone | 688 (56.5%) | 154 (51.3%) | 0.395 |
Prednisolone | 55 (4.5%) | 19 (6.3%) | 0.244 |